This Simplicity Summit session will explore the evolving trajectory of diabetes management with a focus on Linagliptin, highlighting its unique clinical profile, renal safety, and long-term efficacy. The discussion will include the role of DPP-4 inhibitors in simplifying diabetes care, optimizing glycemic control, and addressing comorbidities such as renal impairment. The program will conclude with an interactive Q&A, offering practical insights and real-world perspectives from leading experts.

Simplinacity Summit: Simplifying Diabetes Care with DPP-4 Inhibitors

Head of the Department - Nephrology, Apollo Multi-speciality Hospital, Kolkata

Persistent hypertension despite treatment can often point towards underlying aldosterone-mediated mechanisms. This expert-led session will explore the role of aldosterone in difficult-to-control hypertension, approaches to identifying patients with aldosterone-driven disease, and evolving strategies for targeted management. The discussion will also examine the emerging role of Aldosterone Synthase Inhibitors (ASI) and their potential to address unmet needs in patients with persistently uncontrolled blood pressure. Featuring insights from Dr. Vijay Kher, Prof. Dr. David Wheeler, and Dr. A G Unnikrishnan, the session will focus on practical perspectives and the evolving evidence shaping the future of hypertension management.

Dr. Sandip Kr Bhattacharya

2

751

12k

4.7

Upcoming Sessions

Sessions Taken

870

4.7